Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ELI LILLY & CoLLY · Entity 2794 | SVP & CIDO | February 08, 2021 | February 11, 2021 |
| Elanco Animal Health IncELAN · Entity 3457 | Director | September 19, 2018 | September 19, 2018 |
| NVIDIA CORPNVDA · Entity 1023 | Director | June 25, 2026 | June 29, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ELI LILLY & Co
Report date February 08, 2021 · Filed February 11, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 31,622 |
Reported balance
After 2021-02-08 transaction · row 1
1 source rowRow 1 · 2021-02-08 · Grant · Acquired 11,033 · Balance 31,622 |
| Restricted Stock UnitSEC Table II · derivative / convertible security · Expires 2022-02-01 | Direct | 4,550 |
Reported balance
After 2021-02-08 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2021-02-08 · Grant · Acquired 4,550 · Balance 4,550 F1: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. |
| Common StockSEC Table I · non-derivative | Indirect401(k) | 2,973 |
Reported balance
Holding disclosure · report date 2021-02-08 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 2,973 |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.
Elanco Animal Health Inc
Report date September 19, 2018 · Filed September 19, 2018
This filing explicitly reported no securities owned.
NVIDIA CORP
Report date June 25, 2026 · Filed June 29, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| CommonSEC Table I · non-derivative | Direct | 37,218 |
Reported balance
After 2026-06-25 transaction · row 1
1 source rowRow 1 · 2026-06-25 · Grant · Acquired 1,211 · Balance 37,218 F1: Annual grant in connection with service on the Board of Directors. The shares represent restricted stock units that were received as an award, for no consideration. The restricted stock units shall vest as to 50% of the shares on November 18, 2026 and 50% of the shares on May 19, 2027. If the Reporting Person's service as a director terminates at any time due to death, the grant shall immediately become fully vested. |
Filing footnotes · ownership attribution and instrument terms
F1: Annual grant in connection with service on the Board of Directors. The shares represent restricted stock units that were received as an award, for no consideration. The restricted stock units shall vest as to 50% of the shares on November 18, 2026 and 50% of the shares on May 19, 2027. If the Reporting Person's service as a director terminates at any time due to death, the grant shall immediately become fully vested.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 25, 2026 Filed Jun 29, 2026 21:06 UTC | NVIDIA CORP NVDA · Entity 1023 | GrantCommon | 1,211 | $0.00 | $0.00 |
DisclosureSEC source: 0001725292-26-000004 · wk-form4_1782767179.xml · nonDerivative · entry 1 Shah Aarti S. · CIK 0001725292 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,218 F1 · price: Annual grant in connection with service on the Board of Directors. The shares represent restricted stock units that were received as an award, for no consideration. The restricted stock units shall vest as to 50% of the shares on November 18, 2026 and 50% of the shares on May 19, 2027. If the Reporting Person's service as a director terminates at any time due to death, the grant shall immediately become fully vested. Read SEC document |
| March 19, 2026 Filed Mar 21, 2026 00:14 UTC | NVIDIA CORP NVDA · Entity 1023 | SaleCommon | 202 | $177.73 | $35,902.17 |
DisclosureSEC source: 0001725292-26-000002 · wk-form4_1774052040.xml · nonDerivative · entry 3 Shah Aarti S. · CIK 0001725292 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 36,007 F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 25, 2024. F4 · price: Represents weighted average sales price. The shares were sold at prices ranging from $177.575 to $177.880. The Reporting Person will provide upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| March 19, 2026 Filed Mar 21, 2026 00:14 UTC | NVIDIA CORP NVDA · Entity 1023 | SaleCommon | 10,282 | $177.06 | $1,820,494.93 |
DisclosureSEC source: 0001725292-26-000002 · wk-form4_1774052040.xml · nonDerivative · entry 2 Shah Aarti S. · CIK 0001725292 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 36,209 F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 25, 2024. F3 · price: Represents weighted average sales price. The shares were sold at prices ranging from $176.590 to $177.570. The Reporting Person will provide upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| March 19, 2026 Filed Mar 21, 2026 00:14 UTC | NVIDIA CORP NVDA · Entity 1023 | SaleCommon | 8,516 | $176.27 | $1,501,151.94 |
DisclosureSEC source: 0001725292-26-000002 · wk-form4_1774052040.xml · nonDerivative · entry 1 Shah Aarti S. · CIK 0001725292 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 46,491 F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 25, 2024. F2 · price: Represents weighted average sales price. The shares were sold at prices ranging from $175.820 to $176.570. The Reporting Person will provide upon request, to the Securities and Exchange Commission (the "SEC"), the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| June 26, 2025 Filed Jun 30, 2025 21:00 UTC | NVIDIA CORP NVDA · Entity 1023 | GrantCommon | 1,799 | $0.00 | $0.00 |
DisclosureSEC source: 0001045810-25-000174 · wk-form4_1751317235.xml · nonDerivative · entry 1 Shah Aarti S. · CIK 0001725292 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,007 F1 · price: Annual grant in connection with service on the Board of Directors. The shares represent restricted stock units that were received as an award, for no consideration. The restricted stock units shall vest as to 50% of the shares on November 19, 2025 and 50% of the shares on May 20, 2026. If the Reporting Person's service as a director terminates at any time due to death, the grant shall immediately become fully vested. Read SEC document |
| March 20, 2025 Filed Mar 22, 2025 00:44 UTC | NVIDIA CORP NVDA · Entity 1023 | SaleCommon | 8,476 | $118.87 | $1,007,502.28 |
DisclosureSEC source: 0001045810-25-000071 · wk-form4_1742604293.xml · nonDerivative · entry 3 Shah Aarti S. · CIK 0001725292 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 53,208 F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 25, 2024. F4 · price: Represents weighted average sales price. The shares were sold at prices ranging from $118.66 to $119.39. The Reporting Person will provide upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| March 20, 2025 Filed Mar 22, 2025 00:44 UTC | NVIDIA CORP NVDA · Entity 1023 | SaleCommon | 9,224 | $118.36 | $1,091,792.30 |
DisclosureSEC source: 0001045810-25-000071 · wk-form4_1742604293.xml · nonDerivative · entry 2 Shah Aarti S. · CIK 0001725292 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 61,684 F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 25, 2024. F3 · price: Represents weighted average sales price. The shares were sold at prices ranging from $117.66 to $118.65. The Reporting Person will provide upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| March 20, 2025 Filed Mar 22, 2025 00:44 UTC | NVIDIA CORP NVDA · Entity 1023 | SaleCommon | 2,300 | $116.99 | $269,082.52 |
DisclosureSEC source: 0001045810-25-000071 · wk-form4_1742604293.xml · nonDerivative · entry 1 Shah Aarti S. · CIK 0001725292 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 70,908 F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 25, 2024. F2 · price: Represents weighted average sales price. The shares were sold at prices ranging from $116.59 to $117.47. The Reporting Person will provide upon request, to the Securities and Exchange Commission (the "SEC"), the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| June 27, 2024 Filed Jul 1, 2024 20:49 UTC | NVIDIA CORP NVDA · Entity 1023 | GrantCommon | 2,088 | $0.00 | $0.00 |
DisclosureSEC source: 0001045810-24-000200 · wk-form4_1719866971.xml · nonDerivative · entry 1 Shah Aarti S. · CIK 0001725292 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 73,208 F1 · price: Annual grant in connection with service on the Board of Directors. The shares represent restricted stock units that were received as an award, for no consideration. The restricted stock units shall vest as to 50% of the shares on November 20, 2024 and 50% of the shares on May 21, 2025. If the Reporting Person's service as a director terminates at any time due to death, the grant shall immediately become fully vested. F2 · balance_after: Adjusted to reflect a ten-for-one forward split of the Issuer's common stock effective after market close on June 7, 2024. Read SEC document |
| June 23, 2023 Filed Jun 27, 2023 22:28 UTC | NVIDIA CORP NVDA · Entity 1023 | GrantCommon | 650 | $0.00 | $0.00 |
DisclosureSEC source: 0001045810-23-000156 · wk-form4_1687904907.xml · nonDerivative · entry 1 Shah Aarti S. · CIK 0001725292 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,112 F1 · price: Annual grant in connection with service on the Board of Directors. The shares represent restricted stock units that were received as an award, for no consideration. The restricted stock units shall vest as to 50% of the shares on November 15, 2023 and 50% of the shares on May 15, 2024. If the Reporting Person's service as a director terminates at any time due to death, the grant shall immediately become fully vested. Read SEC document |
| June 03, 2022 Filed Jun 7, 2022 22:21 UTC | NVIDIA CORP NVDA · Entity 1023 | GrantCommon | 1,438 | $0.00 | $0.00 |
DisclosureSEC source: 0001045810-22-000109 · wf-form4_165464050553519.xml · nonDerivative · entry 1 Shah Aarti S. · CIK 0001725292 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,462 F1 · price: Annual grant in connection with service on the Board of Directors. The shares represent restricted stock units that were received as an award, for no consideration. The restricted stock units shall vest as to 50% of the shares on November 16, 2022 and 50% of the shares on May 17, 2023. If the Reporting Person's service as a director terminates at any time due to death, the grant shall immediately become fully vested. F2 · balance_after: Adjusted to reflect a four-for-one forward split of the Issuer's common stock in the form of a stock dividend distributed on July 19, 2021. Read SEC document |
| June 04, 2021 Filed Jun 8, 2021 20:11 UTC | NVIDIA CORP NVDA · Entity 1023 | GrantCommon | 429 | $0.00 | $0.00 |
DisclosureSEC source: 0001045810-21-000094 · wf-form4_162318305050275.xml · nonDerivative · entry 1 Shah Aarti S. · CIK 0001725292 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,256 F1 · price: Annual grant in connection with service on the Board of Directors. The shares represent restricted stock units that were received as an award, for no consideration. The restricted stock units shall vest as to 214 of the shares on November 17, 2021 and 215 of the shares on May 18, 2022. If the Reporting Person's service as a director terminates at any time due to death, the grant shall immediately become fully vested. Read SEC document |
| February 08, 2021 Filed Feb 11, 2021 01:43 UTC | ELI LILLY & Co LLY · Entity 2794 | GrantRestricted Stock Unit · Derivative | 4,550 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-21-000060 · wf-form4_161300776263267.xml · derivative · entry 3 Shah Aarti S. · CIK 0001725292 · SVP & CIDO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,550 Underlying: Common Stock · 4,550 shares Expires 2022-02-01 F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. Read SEC document |
| February 08, 2021 Filed Feb 11, 2021 01:43 UTC | ELI LILLY & Co LLY · Entity 2794 | GrantCommon Stock | 11,033 | $205.77 | $2,270,260.41 |
DisclosureSEC source: 0000059478-21-000060 · wf-form4_161300776263267.xml · nonDerivative · entry 1 Shah Aarti S. · CIK 0001725292 · SVP & CIDO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,622 Read SEC document |
| February 01, 2021 Filed Feb 4, 2021 00:02 UTC | ELI LILLY & Co LLY · Entity 2794 | Exercise / conversionRestricted Stock Unit · Derivative | 6,282 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-21-000032 · wf-form4_161239691232704.xml · derivative · entry 4 Shah Aarti S. · CIK 0001725292 · SVP & CIDO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,282 shares Expires 2021-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. Read SEC document |
| February 01, 2021 Filed Feb 4, 2021 00:02 UTC | ELI LILLY & Co LLY · Entity 2794 | Tax withholdingCommon Stock | 2,780 | $207.97 | $578,156.60 |
DisclosureSEC source: 0000059478-21-000032 · wf-form4_161239691232704.xml · nonDerivative · entry 2 Shah Aarti S. · CIK 0001725292 · SVP & CIDO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,589 Read SEC document |
| February 01, 2021 Filed Feb 4, 2021 00:02 UTC | ELI LILLY & Co LLY · Entity 2794 | Exercise / conversionCommon Stock | 6,282 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-21-000032 · wf-form4_161239691232704.xml · nonDerivative · entry 1 Shah Aarti S. · CIK 0001725292 · SVP & CIDO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,369 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 08, 2020 Filed Dec 10, 2020 22:54 UTC | NVIDIA CORP NVDA · Entity 1023 | GrantCommon | 426 | $0.00 | $0.00 |
DisclosureSEC source: 0001045810-20-000199 · wf-form4_160764085371287.xml · nonDerivative · entry 2 Shah Aarti S. · CIK 0001725292 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 827 F2 · price: Initial grant in connection with appointment to the Board of Directors. The shares represent restricted stock units that were received as an award, for no consideration. The restricted stock unit shall vest as to 1/6th of the shares on June 16, 2021 and 1/6th of the shares approximately every six months thereafter, such that the shares are fully vested on approximately the three (3) year anniversary of the date of the grant. If the Reporting Person's service as a director terminates at any time due to death, the grant shall immediately become fully vested. Read SEC document |
| December 08, 2020 Filed Dec 10, 2020 22:54 UTC | NVIDIA CORP NVDA · Entity 1023 | GrantCommon | 401 | $0.00 | $0.00 |
DisclosureSEC source: 0001045810-20-000199 · wf-form4_160764085371287.xml · nonDerivative · entry 1 Shah Aarti S. · CIK 0001725292 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 401 F1 · price: Pro-rated annual grant in connection with service on the Board of Directors. The shares represent restricted stock units that were received as an award, for no consideration. The restricted stock unit shall vest as to 401 shares vesting on May 19, 2021. If the Reporting Person's service as a director terminates at any time due to death, the grant shall immediately become fully vested. Read SEC document |
| April 24, 2020 Filed Feb 2, 2021 22:12 UTC | ELI LILLY & Co LLY · Entity 2794 | GiftCommon Stock | 2,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-21-000014 · wf-form5_161230396101811.xml · nonDerivative · entry 1 Shah Aarti S. · CIK 0001725292 · SVP & CIDO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,087 Read SEC document |
| April 14, 2020 Filed Apr 16, 2020 15:23 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 2,000 | $150.00 | $300,000.00 |
DisclosureSEC source: 0000059478-20-000094 · wf-form4_158705057891294.xml · nonDerivative · entry 1 Shah Aarti S. · CIK 0001725292 · SVP & CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,087 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 31, 2020. Read SEC document |
| February 11, 2020 Filed Feb 13, 2020 23:11 UTC | ELI LILLY & Co LLY · Entity 2794 | GrantRestricted Stock Unit · Derivative | 6,282 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-20-000042 · wf-form4_158163548313358.xml · derivative · entry 3 Shah Aarti S. · CIK 0001725292 · SVP & CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,282 Underlying: Common Stock · 6,282 shares Expires 2021-02-01 F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. Read SEC document |
| February 11, 2020 Filed Feb 13, 2020 23:11 UTC | ELI LILLY & Co LLY · Entity 2794 | GrantCommon Stock | 3,767 | $144.25 | $543,389.75 |
DisclosureSEC source: 0000059478-20-000042 · wf-form4_158163548313358.xml · nonDerivative · entry 1 Shah Aarti S. · CIK 0001725292 · SVP & CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,087 Read SEC document |
| April 05, 2019 Filed Apr 8, 2019 18:54 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 1,800 | $125.85 | $226,530.00 |
DisclosureSEC source: 0000059478-19-000153 · wf-form4_155474967555852.xml · nonDerivative · entry 1 Shah Aarti S. · CIK 0001725292 · SVP & CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,425 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 5, 2019. Read SEC document |
| March 06, 2019 Filed Apr 8, 2019 18:54 UTC | ELI LILLY & Co LLY · Entity 2794 | GiftCommon Stock | 1,105 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-19-000153 · wf-form4_155474967555852.xml · nonDerivative · entry 2 Shah Aarti S. · CIK 0001725292 · SVP & CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,320 Read SEC document |
| February 04, 2019 Filed Feb 7, 2019 00:36 UTC | ELI LILLY & Co LLY · Entity 2794 | GrantCommon Stock | 5,939 | $120.17 | $713,689.63 |
DisclosureSEC source: 0000059478-19-000061 · wf-form4_154949977670609.xml · nonDerivative · entry 1 Shah Aarti S. · CIK 0001725292 · SVP & CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,224 Read SEC document |
| February 04, 2019 Filed Feb 20, 2019 20:47 UTC Amendment | ELI LILLY & Co LLY · Entity 2794 | GrantCommon Stock | 5,940 | $120.17 | $713,809.80 |
DisclosureSEC source: 0000059478-19-000110 · wf-form4a_155069565002259.xml · nonDerivative · entry 1 Shah Aarti S. · CIK 0001725292 · SVP & CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,225 F1 · shares: This amendment is being filed to correctly report the amount acquired in column 4, and to correct the number of securities beneficially owned following the reported transaction, as reported in column 5. F1 · balance_after: This amendment is being filed to correctly report the amount acquired in column 4, and to correct the number of securities beneficially owned following the reported transaction, as reported in column 5. Read SEC document |
| November 09, 2018 Filed Feb 1, 2019 19:00 UTC | ELI LILLY & Co LLY · Entity 2794 | GiftCommon Stock | 1,424 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-19-000016 · wf-form5_154904764268951.xml · nonDerivative · entry 1 Shah Aarti S. · CIK 0001725292 · SVP & CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,285 Read SEC document |
| January 29, 2018 Filed Jan 31, 2018 23:04 UTC | ELI LILLY & Co LLY · Entity 2794 | GrantCommon Stock | 2,868 | $87.60 | $251,236.80 |
DisclosureSEC source: 0000059478-18-000040 · wf-form4_151743985024452.xml · nonDerivative · entry 1 Shah Aarti S. · CIK 0001725292 · SVP & CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,709 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.